Plasmodium falciparum pfhrp2 and pfhrp3 Gene Deletions from Persons with Symptomatic Malaria Infection in Ethiopia, Kenya, Madagascar, and Rwanda
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overall, our study suggests that the ongoing selective pressures exerted on parasite populations in Ethiopia by HRP2-based RDT diagnosis42 and ACT treatment43 might result in co-occurrence of diagnostic and drug resistance, representing a double threat to malaria elimination.”
From Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia (2023) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beshir, K. B., Sepúlveda, N., Bharmal, J., Robinson, A., Mwanguzi, J., Busula, A. O., de Boer, J. G., Sutherland, C., Cunningham, J., & Hopkins, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-15031-2 · Cited by 164 · cited 2×
“However, because of common epitopes on both antigens, they jointly contribute to an overall HRP2-based RDT positive result or laboratory assay signal (6,9).”
Background
Research works printed but not linked: 36
- World Health Organization. Guidelines for the treatment of malaria: 2nd edition. Geneva: The Organization; 2010.
- Plucinski, 2017, Malaria surveys using rapid diagnostic tests and validation of results using post hoc quantification of Plasmodium falciparum histidine-rich protein 2., Malar J, 16, 451, 10.1186/s12936-017-2101-8 · DOI
- Poti, 2020, HRP2: transforming malaria diagnosis, but with caveats., Trends Parasitol, 36, 112, 10.1016/j.pt.2019.12.004 · DOI · Paper page
- Nderu, 2019, Plasmodium falciparum histidine-rich protein (PfHRP2 and 3) diversity in Western and Coastal Kenya., Sci Rep, 9, 1709, 10.1038/s41598-018-38175-1 · DOI
- Fontecha, 2019, Genetic variability of Plasmodium falciparum histidine-rich proteins 2 and 3 in Central America., Malar J, 18, 31, 10.1186/s12936-019-2668-3 · DOI
- Thomson, 2020, Prevalence of Plasmodium falciparum lacking histidine-rich proteins 2 and 3: a systematic review., Bull World Health Organ, 98, 558, 10.2471/BLT.20.250621 · DOI
- Koita, 2012, False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene., Am J Trop Med Hyg, 86, 194, 10.4269/ajtmh.2012.10-0665 · DOI · Paper page
- Wurtz, 2013, Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests., Malar J, 12, 34, 10.1186/1475-2875-12-34 · DOI · Paper page
- Kozycki, 2017, False-negative malaria rapid diagnostic tests in Rwanda: impact of Plasmodium falciparum isolates lacking hrp2 and declining malaria transmission., Malar J, 16, 123, 10.1186/s12936-017-1768-1 · DOI · Paper page
- Funwei, 2019, Molecular surveillance of pfhrp2 and pfhrp3 genes deletion in Plasmodium falciparum isolates and the implications for rapid diagnostic tests in Nigeria., Acta Trop, 196, 121, 10.1016/j.actatropica.2019.05.016 · DOI
- Parr, 2017, Pfhrp2-deleted Plasmodium falciparum parasites in the Democratic Republic of the Congo: a national cross-sectional survey., J Infect Dis, 216, 36
- Thomson, 2019, pfhrp2 and pfhrp3 gene deletions that affect malaria rapid diagnostic tests for Plasmodium falciparum: analysis of archived blood samples from 3 African countries., J Infect Dis, 220, 1444, 10.1093/infdis/jiz335 · DOI
- Iriart, 2020, Misdiagnosis of imported falciparum malaria from African areas due to an increased prevalence of pfhrp2/pfhrp3 gene deletion: the Djibouti case., Emerg Microbes Infect, 9, 1984, 10.1080/22221751.2020.1815590 · DOI
- Berhane, 2018, Major threat to malaria control programs by Plasmodium falciparum lacking histidine-rich protein 2, Eritrea., Emerg Infect Dis, 24, 462, 10.3201/eid2403.171723 · DOI · Paper page
- Halsey, 2017, Capacity Development through the US President’s Malaria Initiative-Supported Antimalarial Resistance Monitoring in Africa Network., Emerg Infect Dis, 23, 23, 10.3201/eid2313.170366 · DOI · Paper page
- Leonard CM, Mohammed H, Tadesse M, McCaffery JN, Nace D, Halsey ES, Missed Plasmodium falciparum and Plasmodium vivax mixed infections in Ethiopia threaten malaria elimination. Am J Top Med Hyg. 2021 Nov 30 [Epub ahead of print]. · DOI
- Chebore, 2020, Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western Kenya., Malar J, 19, 291, 10.1186/s12936-020-03358-7 · DOI
- Dentinger, 2021, Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018., Malar J, 20, 432, 10.1186/s12936-021-03935-4 · doi:10.1186/s12936-021-03935-4
- Uwimana, 2021, Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study., Lancet Infect Dis, 21, 1120, 10.1016/S1473-3099(21)00142-0 · DOI · Paper page
- Plucinski, 2019, Screening for Pfhrp2/3-deleted Plasmodium falciparum, non-falciparum, and low-density malaria infections by a multiplex antigen assay., J Infect Dis, 219, 437, 10.1093/infdis/jiy525 · DOI
- Bakari, 2020, Community-based surveys for Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions in selected regions of mainland Tanzania., Malar J, 19, 391, 10.1186/s12936-020-03459-3 · DOI
- Herman, 2019, Multiplex malaria antigen detection by bead-based assay and molecular confirmation by PCR shows no evidence of Pfhrp2 and Pfhrp3 deletion in Haiti., Malar J, 18, 380, 10.1186/s12936-019-3010-9 · DOI
- Lucchi, 2013, Molecular diagnosis of malaria by photo-induced electron transfer fluorogenic primers: PET-PCR., PLoS One, 8, e56677, 10.1371/journal.pone.0056677 · DOI · Paper page
- Abdallah, 2015, Prevalence of pfhrp2 and pfhrp3 gene deletions in Puerto Lempira, Honduras., Malar J, 14, 19, 10.1186/s12936-014-0537-7 · DOI
- Jones, 2020, One-step PCR: A novel protocol for determination of pfhrp2 deletion status in Plasmodium falciparum., PLoS One, 15, e0236369, 10.1371/journal.pone.0236369 · DOI
- Cheng, 2014, Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting., Malar J, 13, 283, 10.1186/1475-2875-13-283 · DOI · Paper page
- Lee, 2006, Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria., J Clin Microbiol, 44, 2773, 10.1128/JCM.02557-05 · DOI · Paper page
- Lee, 2012, Identification of optimal epitopes for Plasmodium falciparum rapid diagnostic tests that target histidine-rich proteins 2 and 3., J Clin Microbiol, 50, 1397, 10.1128/JCM.06533-11 · DOI
- Gamboa, 2010, A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests., PLoS One, 5, e8091, 10.1371/journal.pone.0008091 · DOI · Paper page
- Golassa, 2020, High prevalence and extended deletions in Plasmodium falciparum hrp2/3 genomic loci in Ethiopia., PLoS One, 15, e0241807, 10.1371/journal.pone.0241807 · DOI
- Alemayehu, 2021, Detection of high prevalence of Plasmodium falciparum histidine-rich protein 2/3 gene deletions in Assosa zone, Ethiopia: implication for malaria diagnosis., Malar J, 20, 109, 10.1186/s12936-021-03629-x · DOI
- Girma, 2019, Prevalence and epidemiological characteristics of asymptomatic malaria based on ultrasensitive diagnostics: a cross-sectional study., Clin Infect Dis, 69, 1003, 10.1093/cid/ciy1005 · DOI
- Willie, 2018, Insights into the performance of SD Bioline Malaria Ag P.f/Pan rapid diagnostic test and Plasmodium falciparum histidine-rich protein 2 gene variation in Madagascar., Am J Trop Med Hyg, 98, 1683, 10.4269/ajtmh.17-0845 · DOI
- Baker, 2010, Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests., Malar J, 9, 129, 10.1186/1475-2875-9-129 · DOI · Paper page
- Plucinski, 2018, Posttreatment HRP2 clearance in patients with uncomplicated Plasmodium falciparum malaria., J Infect Dis, 217, 685, 10.1093/infdis/jix622 · DOI
- Koita, 2012, False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene., Am J Trop Med Hyg, 86, 194, 10.4269/ajtmh.2012.10-0665 · DOI · Paper page
Cited by
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
Fola, A. A., Feleke, S. M., Mohammed, H., Brhane, B. G., Hennelly, C. M., Assefa, A., Crudal, R. M., Reichert, E., Juliano, J. J., Cunningham, J., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01461-4 · Cited by 213
Self-citationZeleke, A. J., Fola, A. A., Tollefson, G. A., Niaré, K., Leonetti, A., Taropawala, O., Marglous, J., Crudale, R., Brhane, B. G., Assefa, A., et al. (2025) · PLOS Pathogens · doi:10.1371/journal.ppat.1013771 · Cited by 12
Self-citation
Metadata
- Authors
- Rogier, E., McCaffery, J. N., Nace, D., Svigel, S. S., Assefa, A., Hwang, J., Kariuki, S., Samuels, A. M., Westercamp, N., Ratsimbasoa, A., Randrianarivelojosia, M., Uwimana, A., Udhayakumar, V., & Halsey, E. S.
- Venue
- Emerging Infectious Diseases
- Published
- 2022-03
- Volume
- 28
- Issue
- 3
- Pages
- 608-616
- ISSN
- 1080-6040
- 1080-6059
- Cited by
- 47
- References
- 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.